Podcast
GLP-1 RAs: What Patients Need To Know
Release Date: March 26, 2021
Expiration Date: March 25, 2022
CE/CME Credit Hours: 0.25
Pharmacology Credit Hours: 0.25
Begin »
Program Overview
Program Description
While highly efficacious, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) should be used in a comprehensive management plan that includes balanced nutrition, adequate exercise, and proper adherence to all medications. In this second of two podcasts, Davida Kruger, NP and Anne Peters, MD share tips and pearls for treating patients with type 2 diabetes using GLP-1 RAs, including when to choose a GLP-1 RA, how to broach the topic of a first injectable, when an oral agent is preferred, ways to encourage lifestyle modifications in a nonjudgmental manner, and practical advice on preparing and monitoring patients with respect to GLP1-RA therapy.
Format
Podcast
Learning Objectives
After completing this activity, participants should be better able to:
- Formulate strategies for use of GLP-1 RAs that include individualized choices of dosing frequencies and routes of administration
- Implement shared decision-making for type 2 diabetes management using available decision tools and evidence-based recommendations
Target Audience
NPs and PAs
Faculty
Davida F. Kruger, MSN, APN-BC, BC-ADM
- Certified Nurse Practitioner
- Division of Endocrinology, Diabetes, and Bone and Mineral Disorders
- Henry Ford Health System
- Detroit, Michigan
Anne Peters, MD
- Director
- USC Clinical Diabetes Programs
- Professor of Clinical Medicine
- Keck School of Medicine of USC
- University of Southern California
- Los Angeles, California
Details
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 0.25, which includes 0.25 hours of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until March 25, 2022. PAs should only claim credit commensurate with the extent of their participation.
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from Novo Nordisk Inc.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Ms Kruger: advisory board: Eli Lilly and Company, Merck, Sanofi-Aventis; advisory board/research support/speakers bureau: Abbott, Dexcom, Novo Nordisk; advisory board/speakers bureau: BI-Lilly, Janssen; advisory board/stock: Pendulum Therapeutics; research support: The Leona M. and Harry B. Helmsley Charitable Trust, Lexicon Pharmaceuticals; speakers bureau: AstraZeneca, Insulet, Lilly, Valeritas.
Dr Peters: advisory board: Abbott Diabetes Care, Bio-Rad, Eli Lilly and Company, MannKind, Medscape, Merck, Novo Nordisk, Zealand; advisory board/stock: Omada Health, Pendulum Therapeutics, Stability Health, Teladoc; research support: Abbott Diabetes Care, Dexcom, vTv Therapeutics.
None of the members of the PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Listen to the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of 100%.
The estimated time to complete this activity is 0.25 hours.
Release date: March 26, 2021
Expiration date: March 25, 2022
For Practicing Clinicians Exchange general information, contact pce@practicingclinicians.com.
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 101020N-2